Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?

Lucia Taramasso; Niccolò Riccardi; Filippo Del Puente; Bianca Bruzzone; Diego Ripamonti; Beatrice D'Ambrosio; Claudio Viscoli; Antonio Di Biagio

doi:10.1089/aid.2017.0112

Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?

AIDS Research and Human Retroviruses ◽

10.1089/aid.2017.0112 ◽

2018 ◽

Vol 34 (2) ◽

pp. 168-170

Author(s):

Lucia Taramasso ◽

Niccolò Riccardi ◽

Filippo Del Puente ◽

Bianca Bruzzone ◽

Diego Ripamonti ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Short Communication ◽

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Longer-Term Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide Versus Emtricitabine and Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Week 96 Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3772801 ◽

2021 ◽

Author(s):

Onyema Ogbuagu ◽

Peter J. Ruane ◽

Daniel Podzamczer ◽

Laura C. Salazar ◽

Keith Henry ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Tenofovir Alafenamide ◽

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis

Drugs ◽

10.1007/s40265-013-0024-4 ◽

2013 ◽

Vol 73 (3) ◽

pp. 279-291 ◽

Cited By ~ 23

Author(s):

Greg L. Plosker

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient

AIDS Research and Human Retroviruses ◽

10.1089/aid.2016.0180 ◽

2017 ◽

Vol 33 (7) ◽

pp. 718-722 ◽

Cited By ~ 9

Author(s):

Maile Young Karris

Keyword(s):

Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Fanconi Syndrome ◽

Short Communication ◽

Tenofovir Alafenamide ◽

Coinfected Patient ◽

Hiv 1

Download Full-text

Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis

AIDS Research and Human Retroviruses ◽

10.1089/aid.2018.0096 ◽

2019 ◽

Vol 35 (2) ◽

pp. 123-128 ◽

Cited By ~ 5

Author(s):

Peter L. Havens ◽

Ashutosh Tamhane ◽

Charles B. Stephensen ◽

Gertrud U. Schuster ◽

Catherine M. Gordon ◽

...

Keyword(s):

Vitamin D ◽

Tenofovir Disoproxil Fumarate ◽

Short Communication ◽

Young Men ◽

Vitamin D Insufficiency ◽

Adolescent Boys ◽

Exposure Prophylaxis ◽

Tenofovir Diphosphate

Download Full-text

Emtricitabine/tenofovir disoproxil fumarate in HIV-1 pre-exposure prophylaxis: a guide to its once-daily use in the EU

Drugs & Therapy Perspectives ◽

10.1007/s40267-016-0363-9 ◽

2016 ◽

Vol 33 (1) ◽

pp. 8-15

Author(s):

Emma D. Deeks ◽

Katherine Lyseng-Williamson ◽

Greg L. Plosker

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Once Daily ◽

Exposure Prophylaxis ◽

Hiv 1 ◽

The Eu

Download Full-text

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet HIV ◽

10.1016/s2352-3018(21)00071-0 ◽

2021 ◽

Vol 8 (7) ◽

pp. e397-e407

Author(s):

Onyema Ogbuagu ◽

Peter J Ruane ◽

Daniel Podzamczer ◽

Laura C Salazar ◽

Keith Henry ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Tenofovir Alafenamide ◽

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Primary HIV-1 infection in users of pre-exposure prophylaxis

The Lancet HIV ◽

10.1016/s2352-3018(20)30271-x ◽

2020 ◽

Author(s):

Juan Ambrosioni ◽

Elisa Petit ◽

Geoffroy Liegeon ◽

Montserrat Laguno ◽

José M Miró

Keyword(s):

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954439.793460355 ◽

2012 ◽

Author(s):

Kiat Ruxrungtham ◽

Wirach Maek-a-nantawat

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Hiv 1

Download Full-text

Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan

HIV Medicine ◽

10.1111/hiv.13061 ◽

2021 ◽

Author(s):

Naoki Kanda ◽

Koh Okamoto ◽

Hisatoshi Okumura ◽

Makiko Mieno ◽

Kentaro Sakashita ◽

...

Keyword(s):

Real World ◽

Tenofovir Disoproxil Fumarate ◽

Treatment Change ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text

Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection

Expert Opinion on Drug Safety ◽

10.1080/14740338.2021.1931680 ◽

2021 ◽

Author(s):

Randy M. Stalter ◽

Jillian Pintye ◽

Kenneth K. Mugwanya

Keyword(s):

At Risk ◽

Hiv Infection ◽

Pregnant Women ◽

Tenofovir Disoproxil Fumarate ◽

Safety Review ◽

Exposure Prophylaxis

Download Full-text